GENERATION OF CD4 T CELLS
Application
US20260083778A1
Kind: A1
Mar 26, 2026
Assignee
BOSTON MEDICAL CENTER CORPORATION
Inventors
Gustavo MOSTOSLAVSKY, Julian AMIRAULT
Abstract
The technology described herein is directed to methods of generating CD4+CD8− single-positive T cells from CD4+CD8+ double positive T progenitor cells using differentiation in the presence of interleukin-7 (IL-7) and an anti-CD3 agent and in absence of Notch ligand and an anti-CD28 agent. Also described herein are CD4+CD8− single-positive T cells made by the methods described herein, which can be used for therapeutic applications.
CPC Classifications
A61K 35/17
A61K 40/11
A61K 40/31
A61K 40/421
A61P 37/04
C07K 14/70514
C12N 5/0018
C12N 5/0636
C12N 2501/155
C12N 2501/165
C12N 2501/2302
C12N 2501/2307
C12N 2501/51
C12N 2501/515
C12N 2501/727
C12N 2506/1369
C12N 2510/00
C12N 2533/52
Filing Date
2025-09-19
Application No.
19334256